Thrombolysis: Clinical Trials

2 trials for Thrombolysis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Thrombolysis: new trials by email Literature Review of Thrombolysis trials Research Report on Thrombolysis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion
Tenecteplase, direct EVT - Ischemic Stroke, Acute, Thrombolysis
Phase 3CompletedBeijing Tiantan Hospital3912024-01-252025-11-26
Tenecteplase in Stroke Patients Between 4.5 and 24 Hours
Tenecteplase, Placebo - THROMBOLYSIS
Phase 3CompletedGenentech, Inc.4582019-03-022024-05-22

Narrower conditions

Infarction, Middle Cerebral Artery (1)  ·  Ischemic Stroke (1)

Broader conditions

Brain Diseases (1)  ·  Brain Infarction (1)  ·  Brain Ischemia (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebral Arterial Diseases (1)  ·  Cerebral Infarction (1)  ·  Cerebrovascular Disorders (1)  ·  Infarction (1)  ·  Intracranial Arterial Diseases (1)  ·  Ischemia (1)  ·  Necrosis (1)  ·  Nervous System Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Tenecteplase (2)

Sponsors

Beijing Tiantan Hospital (1)  ·  Genentech, Inc. (1)

Countries

Canada (1)  ·  China (1)  ·  United States (1)

Top investigators

Fengyuan Che, MD (1)  ·  Yunyun Xiong, MD (1)

Results publications

PMID 35262424, PMID 35369714, PMID 38329148, PMID 42099212